Overall, SHMT2 was upregulated in CRC tissue compared to non-malignant tissue; however, patients with low SHMT2 had worse outcomes and this correlated with elevated LC3-II and p62 consistent with autophagy activation in SHMT2-low, 5-FU-resistant CRC[124]. Here, SHMT2 is linked to colorectal carcinoma.